该公司专门开发独特的技术,旨在快速检测、处理或净化特定微生物的存在。目前,美国国家卫生和健康研究所生产的检测试剂盒旨在识别与动物和人类传染病有关的微生物(a);(b)食品污染;(c)生物战争;(d)环境危害。
was founded in 1981. It has developed rapid microbial detection technologies, including the first gold-based immunoassay and a luminescent-based ATP detection System that discriminates microbial from somatic cell responses.
Innovation and critical alliances have hallmarked the continuing success of New Horizons. The company has expanded its technology base to include the prevention and treatment of autoimmune and infectious diseases. These include the use of humanized anti-cytokine monoclonal antibodies and the treatment of bacterial infection with Phage associated lytic enzymes. New test formats include a hand held ultra-sensitive fluorescence system and methods for testing oral fluids with point-of-care diagnostic devices.
The company specializes in the development of unique technologies that have been designed to rapidly detect, treat, or decontaminate the presence of selected microorganisms. Currently, NHD manufactures test kits designed to identify microorganisms associated with (a) infectious diseases in animals and humans; (b) food contamination; (c) biological warfare; and (d) environmental hazards.